Erdafitinib Intravesical Delivery System clinical trials

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

This study is testing a new way to deliver a bladder cancer drug, Erdafitinib, directly into the bladder. It's for people with certain types of bladder cancer. Researchers want to find the best dose and see how well it works to treat cancer and reduce side effects.